Published: 6 September 2018

Publications

Quarterly Summary of Recent Safety Communications

This article is more than five years old. Some content may no longer be current.

Prescriber Update 39(3): 42
September 2018

The table below is a summary of recent safety communications to healthcare professionals and consumers. (Find out about subscribing to Medsafe's updates and alerts.)

The early warning system provides current and historical information on safety concerns for medicines and medical devices. These warnings are intended to help consumers and healthcare professionals make informed decisions about their use of medicines and medical devices. More information about the early warning system is available on the Medsafe website (www.medsafe.govt.nz/Projects/B2/EWS.asp).

Date	Communication	Topic
14 August 2018	Medicines Monitoring	Isotretinoin and obsessive compulsive disorder added to the Medicines Monitoring scheme
13 August 2018	Alert Communication	Codeine – new restrictions on use in children and young adults
13 August 2018	Dear Healthcare Professional Letter	Bicillin – changes to expression of product strength
6 August 2018	Monitoring Communication	Dolutegravir and the possible risk of neural tube defects when taken early in pregnancy
27 July 2018	Alert Communication	Consumer Level Recall – Melatonin 3 mg tablets (Worldwide Labs)
25 July 2018	Consumer Information Leaflet	Taking metformin for gestational diabetes – now available in te reo Māori and Samoan
19 July 2018	Dear Healthcare Professional Letter	Dissolution profile of Dilantin® 30 mg and 100 mg capsules (New Formulation)
3 July 2018	Dear Healthcare Professional Letter	Provisional consent of Neulactil periciazine 2.5 mg and 10 mg tablets (Hong Kong stock) to cover temporary stock shortage